{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:07:55Z","timestamp":1789664875289,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41433-024-03408-3","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:02:19Z","timestamp":1730300539000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema"],"prefix":"10.1038","volume":"39","author":[{"given":"Walid","family":"Bouthour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau B.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-850X","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Biousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"3408_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159\u201365.","journal-title":"Neurology"},{"key":"3408_CR2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol, Neurosurg Psychiatry. 2018;89:1088.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"3408_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1212\/WNL.0000000000001896","volume":"85","author":"M Wall","year":"2015","unstructured":"Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015;85:799\u2013805.","journal-title":"Neurology"},{"key":"3408_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S0002-9394(14)73425-7","volume":"96","author":"M Wall","year":"1983","unstructured":"Wall M, Hart WM, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 1983;96:654\u201369.","journal-title":"Am J Ophthalmol"},{"key":"3408_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/archneur.1987.00520140040015","volume":"44","author":"M Wall","year":"1987","unstructured":"Wall M. George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy. Arch Neurol. 1987;44:170\u20135.","journal-title":"Arch Neurol"},{"key":"3408_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archneur.1982.00510200003001","volume":"39","author":"JJ Corbett","year":"1982","unstructured":"Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461\u201374.","journal-title":"Arch Neurol"},{"key":"3408_CR7","first-page":"541","volume":"55","author":"JA Rush","year":"1980","unstructured":"Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc. 1980;55:541\u20136.","journal-title":"Mayo Clin Proc"},{"key":"3408_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0161-6420(84)34149-5","volume":"91","author":"JC Orcutt","year":"1984","unstructured":"Orcutt JC, Page NGR, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology. 1984;91:1303\u201312.","journal-title":"Ophthalmology"},{"key":"3408_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/brain\/114.2.1112","volume":"114","author":"M Wall","year":"1991","unstructured":"Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain: A J Neurol. 1991;114:155\u201380.","journal-title":"Brain: A J Neurol"},{"key":"3408_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/01658107.2021.1984540","volume":"46","author":"R Behbehani","year":"2022","unstructured":"Behbehani R, Ali A, Al-Moosa A. Course and predictors of visual outcome of idiopathic intracranial hypertension. Neuro-Ophthalmol. 2022;46:80\u20134.","journal-title":"Neuro-Ophthalmol"},{"key":"3408_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/archneur.1988.00520320056015","volume":"45","author":"KB Digre","year":"1988","unstructured":"Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol. 1988;45:866\u201372.","journal-title":"Arch Neurol"},{"key":"3408_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.wnl.0000333254.84120.f5","volume":"72","author":"BB Bruce","year":"2009","unstructured":"Bruce BB, Kedar S, Stavern GPV, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304\u20139.","journal-title":"Neurology"},{"key":"3408_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/01.wnl.0000304746.92913.dc","volume":"70","author":"BB Bruce","year":"2008","unstructured":"Bruce BB, Preechawat P, Newman NJ, Lynn MJ, Biousse V. Racial differences in idiopathic intracranial hypertension. Neurology. 2008;70:861\u20137.","journal-title":"Neurology"},{"key":"3408_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/WNO.0b013e31823f852d","volume":"33","author":"AJ Szewka","year":"2013","unstructured":"Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuro-Ophthalmol. 2013;33:4\u20138.","journal-title":"J Neuro-Ophthalmol"},{"key":"3408_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0002-9394(02)02062-7","volume":"135","author":"V Biousse","year":"2003","unstructured":"Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol. 2003;135:437\u201346.","journal-title":"Am J Ophthalmol"},{"key":"3408_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/WNO.0000000000001715","volume":"43","author":"I Sverdlichenko","year":"2023","unstructured":"Sverdlichenko I, Yu CW, Margolin E, Micieli JA. Comparison of idiopathic intracranial hypertension patients with and without anemia. J Neuro-Ophthalmol. 2023;43:535\u201340.","journal-title":"J Neuro-Ophthalmol"},{"key":"3408_CR17","first-page":"134","volume":"39","author":"M Wall","year":"1998","unstructured":"Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Investig Ophthalmol Vis Sci. 1998;39:134\u201342.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3408_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/bjophthalmol-2015-307043","volume":"100","author":"SM Gospe","year":"2016","unstructured":"Gospe SM, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100:505.","journal-title":"Br J Ophthalmol"},{"key":"3408_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","volume":"68","author":"M Thambisetty","year":"2007","unstructured":"Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68:229\u201332.","journal-title":"Neurology"},{"key":"3408_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1167\/iovs.15-18626","volume":"57","author":"M Wall","year":"2016","unstructured":"Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL, et al. Visual field outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Investig Ophthalmol Vis Sci. 2016;57:805\u201312.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3408_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/tjo.tjo_44_20","volume":"11","author":"JA Micieli","year":"2020","unstructured":"Micieli JA, Gorham JP, Bruce BB, Newman NJ, Biousse V, Peragallo JH. Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema. Taiwan J Ophthalmol. 2020;11:53\u20136.","journal-title":"Taiwan J Ophthalmol"},{"key":"3408_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1017\/cjn.2020.89","volume":"47","author":"JA Micieli","year":"2020","unstructured":"Micieli JA, Bruce BB, Vasseneix C, Blanch RJ, Berezovsky DE, Newman NJ, et al. Influence of optic nerve appearance on visual outcome in pediatric idiopathic intracranial hypertension. Can J Neurol Sci J Can des Sci Neurol. 2020;47:661\u20135.","journal-title":"Can J Neurol Sci J Can des Sci Neurol"},{"key":"3408_CR23","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/bjophthalmol-2018-313329","volume":"103","author":"JA Micieli","year":"2019","unstructured":"Micieli JA, Bruce BB, Vasseneix C, Blanch RJ, Berezovsky DE, Peragallo JH, et al. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension. Br J Ophthalmol. 2019;103:1429.","journal-title":"Br J Ophthalmol"},{"key":"3408_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2214\/AJR.12.9638","volume":"201","author":"AM Saindane","year":"2013","unstructured":"Saindane AM, Bruce BB, Riggeal BD, Newman NJ, Biousse V. Association of MRI findings and visual outcome in idiopathic intracranial hypertension. Am J Roentgenol. 2013;201:412\u20138.","journal-title":"Am J Roentgenol"},{"key":"3408_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41433-018-0238-5","volume":"33","author":"SP Mollan","year":"2019","unstructured":"Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ. The expanding burden of idiopathic intracranial hypertension. Eye. 2019;33:478\u201385.","journal-title":"Eye"},{"key":"3408_CR26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208036","volume":"102","author":"JK Shaia","year":"2024","unstructured":"Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, et al. Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity. Neurology. 2024;102:e208036.","journal-title":"Neurology"},{"key":"3408_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","volume":"45","author":"L Fris\u00e9n","year":"1982","unstructured":"Fris\u00e9n L. Swelling of the optic nerve head: a staging scheme. J Neurology Neurosurg Psychiatry. 1982;45:13.","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"3408_CR28","unstructured":"Hoyt W, Beeston D. The ocular fundus in neurologic disease: a diagnostic manual and stereo atlas. St Louis: Mosby; 1966."},{"key":"3408_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.survophthal.2006.12.008","volume":"52","author":"P Brusini","year":"2007","unstructured":"Brusini P, Johnson CA. Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol. 2007;52:156\u201379.","journal-title":"Surv Ophthalmol"},{"key":"3408_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/IJG.0b013e31821dac66","volume":"21","author":"M Ng","year":"2012","unstructured":"Ng M, Sample PA, Pascual JP, Zangwill LM, Girkin CA, Liebmann JM, et al. Comparison of visual field severity classification systems for glaucoma. J Glaucoma. 2012;21:551\u201361.","journal-title":"J Glaucoma"},{"key":"3408_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/CPJ.0000000000000115","volume":"5","author":"DD Mackay","year":"2015","unstructured":"Mackay DD, Garza PS, Bruce BB, Newman NJ, Biousse V. The demise of direct ophthalmoscopy. Neurology Clin Pract. 2015;5:150\u20137.","journal-title":"Neurology Clin Pract"},{"key":"3408_CR32","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1212\/WNL.0000000000004895","volume":"90","author":"V Sachdeva","year":"2018","unstructured":"Sachdeva V, Vasseneix C, Hage R, Bidot S, Clough LC, Wright DW, et al. Optic nerve head edema among patients presenting to the emergency department. Neurology. 2018;90:e373\u20139.","journal-title":"Neurology"},{"key":"3408_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMc1009733","volume":"364","author":"BB Bruce","year":"2011","unstructured":"Bruce BB, Lamirel C, Wright DW, Ward A, Heilpern KL, Biousse V, et al. Nonmydriatic ocular fundus photography in the Emergency Department. New Engl J Medicine. 2011;364:387\u20139.","journal-title":"New Engl J Medicine"},{"key":"3408_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.annemergmed.2013.01.010","volume":"62","author":"BB Bruce","year":"2013","unstructured":"Bruce BB, Thulasi P, Fraser CL, Keadey MT, Ward A, Heilpern KL, et al. Diagnostic accuracy and use of monmydriatic ocular fundus photography by emergency physicians: phase II of the FOTO-ED study. Ann Emerg Med. 2013;62:28\u201333.e1.","journal-title":"Ann Emerg Med"},{"key":"3408_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/WNO.0000000000001031","volume":"41","author":"L Stunkel","year":"2020","unstructured":"Stunkel L, Newman-Toker DE, Newman NJ, Biousse V. Diagnostic error of neuro-ophthalmologic conditions: state of the science. J Neuro-ophthalmol. 2020;41:98\u2013113.","journal-title":"J Neuro-ophthalmol"},{"key":"3408_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ajo.2013.06.022","volume":"156","author":"LP Kelly","year":"2013","unstructured":"Kelly LP, Garza PS, Bruce BB, Graubart EB, Newman NJ, Biousse V. Teaching ophthalmoscopy to medical students (the TOTeMS study). Am J Ophthalmol. 2013;156:1056\u20131061.e10.","journal-title":"Am J Ophthalmol"},{"key":"3408_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/NRL.0000000000000259","volume":"25","author":"NK Irani","year":"2020","unstructured":"Irani NK, Bidot S, Peragallo JH, Esper GJ, Newman NJ, Biousse V. Feasibility of a nonmydriatic ocular fundus camera in an outpatient neurology clinic. Neurologist. 2020;25:19\u201323.","journal-title":"Neurologist"},{"key":"3408_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01658107.2017.1419368","volume":"42","author":"BB Bruce","year":"2018","unstructured":"Bruce BB, Bidot S, Hage R, Clough LC, Fajoles-Vasseneix C, Melomed M, et al. Fundus photography vs. ophthalmoscopy outcomes in the Emergency Department (FOTO-ED) phase III: web-based, in-service training of emergency providers. Neuro-ophthalmology. 2018;42:1\u20136.","journal-title":"Neuro-ophthalmology"},{"key":"3408_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1212\/WNL.0000000000004868","volume":"90","author":"V Biousse","year":"2018","unstructured":"Biousse V, Bruce BB, Newman NJ. Ophthalmoscopy in the 21st century. Neurology. 2018;90:167\u201375.","journal-title":"Neurology"},{"key":"3408_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/01658107.2023.2176522","volume":"47","author":"W Bouthour","year":"2023","unstructured":"Bouthour W, Biousse V, Newman NJ. Diagnosis of optic disc oedema: fundus features, ocular imaging findings, and artificial intelligence. Neuro-Ophthalmol. 2023;47:177\u201392.","journal-title":"Neuro-Ophthalmol"},{"key":"3408_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMoa1917130","volume":"382","author":"D Milea","year":"2020","unstructured":"Milea D, Najjar RP, Zhubo J, Ting D, Vasseneix C, Xu X, et al. Artificial intelligence to detect papilledema from ocular fundus photographs. New Engl J Med. 2020;382:1687\u201395.","journal-title":"New Engl J Med"},{"key":"3408_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajo.2023.10.025","volume":"261","author":"V Biousse","year":"2024","unstructured":"Biousse V, Najjar RP, Tang Z, Lin MY, Wright DW, Keadey MT, et al. Application of a deep learning system to detect papilledema on nonmydriatic ocular fundus photographs in an Emergency Department. Am J Ophthalmol. 2024;261:199\u2013207.","journal-title":"Am J Ophthalmol"},{"key":"3408_CR43","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1038\/s41433-022-02361-3","volume":"37","author":"V Biousse","year":"2023","unstructured":"Biousse V, Newman NJ. The expanding spectrum of idiopathic intracranial hypertension. Eye. 2023;37:2361\u20134.","journal-title":"Eye"},{"key":"3408_CR44","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/s41433-024-03140-y","volume":"38","author":"L Bonelli","year":"2024","unstructured":"Bonelli L, Menon V, Arnold AC, Mollan SP. Managing idiopathic intracranial hypertension in the eye clinic. Eye. 2024;38:2472\u201381.","journal-title":"Eye"},{"key":"3408_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/WNO.0000000000001594","volume":"42","author":"T Brady","year":"2022","unstructured":"Brady T, Vegunta S, Crum AV, Marx D, Patel BCK, Seay MD, et al. Interdisciplinary protocol for the management of vision-threatening papilledema. J Neuro-Ophthalmol. 2022;42:495\u2013501.","journal-title":"J Neuro-Ophthalmol"},{"key":"3408_CR46","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ophtha.2023.07.028","volume":"130","author":"ALO Smolar","year":"2023","unstructured":"Smolar ALO, Ray HJ, Dattilo M, Bouthour W, Berman G, Peragallo JH, et al. Neuro-ophthalmology emergency department and inpatient consultations at a large academic referral center. Ophthalmology. 2023;130:1304\u201312.","journal-title":"Ophthalmology"},{"key":"3408_CR47","doi-asserted-by":"publisher","unstructured":"Ray HJ, Smolar ALO, Dattilo M, Bouthour W, Berman G, Peragallo JH, et al. The increasing burden of Emergency Department and inpatient consultations for \u201cPapilledema.\u201d J Neuro-Ophthalmol. 2024. https:\/\/doi.org\/10.1097\/WNO.0000000000002120.","DOI":"10.1097\/WNO.0000000000002120"},{"key":"3408_CR48","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. New Engl J Med. 2019;381:2440\u201350.","journal-title":"New Engl J Med"},{"key":"3408_CR49","first-page":"31","volume":"70","author":"JJ Craig","year":"2001","unstructured":"Craig JJ, Mulholland DA, Gibson JM. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulst Med J. 2001;70:31\u20135.","journal-title":"Ulst Med J"},{"key":"3408_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/112067210401400108","volume":"14","author":"A Carta","year":"2003","unstructured":"Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol. 2003;14:48\u201354.","journal-title":"Eur J Ophthalmol"},{"key":"3408_CR51","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.neurol.2008.11.021","volume":"165","author":"S Mrejen","year":"2009","unstructured":"Mrejen S, Vignal C, Bruce BB, Gineys R, Audren F, Preechawat P, et al. Idiopathic intracranial hypertension: a comparison between French and North-American white patients. Rev Neurol. 2009;165:542\u20138.","journal-title":"Rev Neurol"},{"key":"3408_CR52","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41433-019-0359-5","volume":"33","author":"RJ Blanch","year":"2019","unstructured":"Blanch RJ, Vasseneix C, Liczkowski A, Yiangou A, Aojula A, Micieli JA, et al. Differing presenting features of idiopathic intracranial hypertension in the UK and US. Eye. 2019;33:1014\u20139.","journal-title":"Eye"},{"key":"3408_CR53","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00415-022-11402-6","volume":"270","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, et al. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2023;270:851\u201363.","journal-title":"J Neurol"},{"key":"3408_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/WNO.0000000000001214","volume":"42","author":"A DeBusk","year":"2022","unstructured":"DeBusk A, Subramanian PS, Bryan MS, Moster ML, Calvert PC, Frohman LP. Mismatch in supply and demand for neuro-ophthalmic care. J Neuro-Ophthalmol. 2022;42:62\u20137.","journal-title":"J Neuro-Ophthalmol"},{"key":"3408_CR55","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/s41433-024-03141-x","volume":"38","author":"SP Mollan","year":"2024","unstructured":"Mollan SP, Menon V, Cunningham A, Plant GT, Bennetto L, Wong SH, et al. Neuro-ophthalmology in the United Kingdom: providing a sustainable, safe and high-quality service for the future. Eye (Lond). 2024;38:2235\u20137.","journal-title":"Eye (Lond)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03408-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:11:12Z","timestamp":1736885472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03408-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors have any competing interest. VB is consultant for GenSight Biologics, Neurophoenix\u00a0and Topcon. NJN is consultant for GenSight Biologics, Santhera\/Chiesi, Stoke, and Neurophoenix; receives research support from GenSight Biologics and Santhera\/Chiesi. VB, NJN are supported by the National Institutes of Health\u2019s National Eye Institute core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine) and by a departmental grant from Research to Prevent Blindness (New York, NY). WB received a scholarship from Geneva University Hospitals, Geneva, Switzerland.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}